Endotoxin Tolerance Represents a Distinctive State of Alternative Polarization (M2) in Human Mononuclear Cells

Classical (M1) and alternative (M2) polarization of mononuclear cells (MNCs) such as monocyte and macrophages is known to occur in response to challenges within a microenvironment, like the encounter of a pathogen. LPS, also known as endotoxin, is a potent inducer of inflammation and M1 polarization. LPS can also generate an effect in MNCs known as endotoxin tolerance, defined as the reduced capacity of a cell to respond to LPS activation after an initial exposure to this stimulus. Using systems biology approaches in PBMCs, monocytes, and monocyte-derived macrophages involving microarrays and advanced bioinformatic analysis, we determined that gene responses during endotoxin tolerance were similar to those found during M2 polarization, featuring gene and protein expression critical for the development of key M2 MNC functions, including reduced production of proinflammatory mediators, expression of genes involved in phagocytosis, as well as tissue remodeling. Moreover, expression of different metallothionein gene isoforms, known for their role in the control of oxidative stress and in immunomodulation, were also found to be consistently upregulated during endotoxin tolerance. These results demonstrate that after an initial inflammatory stimulus, human MNCs undergo an M2 polarization probably to control hyperinflammation and heal the affected tissue.

[1]  J. Paulauskis,et al.  Role of the Scavenger Receptor MARCO in Alveolar Macrophage Binding of Unopsonized Environmental Particles , 1999, The Journal of experimental medicine.

[2]  D. Dombrowicz,et al.  Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells , 2007, Cancer Immunology, Immunotherapy.

[3]  P. Beeson Development of Tolerance to Typhoid Bacterial Pyrogen and its Abolition by Reticulo-Endothelial Blockade.∗ , 1946, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[4]  F. Schildberg,et al.  Downregulation of proinflammatory cytokine release in whole blood from septic patients. , 1995, Blood.

[5]  R. Geha,et al.  Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes , 1988, The Journal of experimental medicine.

[6]  B. Brüne,et al.  Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages. , 2001, The FASEB Journal.

[7]  M. Sato,et al.  Protective role of metallothionein in acute lung injury induced by bacterial endotoxin , 2004, Thorax.

[8]  B. Brüne,et al.  Delayed activation of PPARγ by LPS and IFN-γ attenuates the oxidative burst in macrophages , 2001 .

[9]  C. Legrand,et al.  Airway Epithelial Cell Migration Dynamics , 1999, The Journal of cell biology.

[10]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[11]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[12]  Simmie L. Foster,et al.  Gene-specific control of inflammation by TLR-induced chromatin modifications , 2007, Nature.

[13]  C. del Fresno,et al.  Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. , 2003, Biochemical and biophysical research communications.

[14]  R. Utili,et al.  Enhanced phagocytosis and bactericidal activity of hepatic reticuloendothelial system during endotoxin tolerance. , 1980, Infection and immunity.

[15]  R. Hancock,et al.  Human Cathelicidin Peptide LL-37 Modulates the Effects of IFN-γ on APCs1 , 2009, The Journal of Immunology.

[16]  L. Ivashkiv,et al.  Regulation of macrophage phenotype by long-term exposure to IL-10. , 2005, Immunobiology.

[17]  S. Barber,et al.  Differential expression of interferon regulatory factor 1 (IRF-1), IRF-2, and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages , 1995, Infection and immunity.

[18]  R. Hotchkiss,et al.  Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1 , 2001, The Journal of Immunology.

[19]  K. Goss,et al.  VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[20]  H. Volk,et al.  Impaired antigen presentation by human monocytes during endotoxin tolerance , 2000 .

[21]  Richard G. Jenner,et al.  Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Tisha Wang,et al.  Molecular and cellular aspects of sepsis-induced immunosuppression , 2008, Journal of Molecular Medicine.

[23]  T. Libermann,et al.  ELF-1 Is a Transcriptional Regulator of the Tie2 Gene During Vascular Development , 2001, Circulation research.

[24]  C. Galanos,et al.  Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages , 1988, Infection and immunity.

[25]  Annemarie H Meijer,et al.  Macrophage-specific gene functions in Spi1-directed innate immunity. , 2010, Blood.

[26]  P. De Baetselier,et al.  Alternatively activated macrophages during parasite infections. , 2004, Trends in parasitology.

[27]  Anne-Katrin Greul,et al.  Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. , 2007, American journal of respiratory cell and molecular biology.

[28]  A. Sica,et al.  M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro1 , 2009, The Journal of Immunology.

[29]  P. De Baetselier,et al.  Arginase-1 and Ym1 Are Markers for Murine, but Not Human, Alternatively Activated Myeloid Cells , 2005, The Journal of Immunology.

[30]  S. Haulon,et al.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. , 2007, Cell metabolism.

[31]  Matthew R. Laird,et al.  Protein Protein Interaction Network Evaluation for Identifying Potential Drug Targets , 2009 .

[32]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[33]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[34]  M. Malavolta,et al.  Zinc, Immune Plasticity, Aging, and Successful Aging: Role of Metallothionein , 2004, Annals of the New York Academy of Sciences.

[35]  H. Patel,et al.  Cross-talk between transcription factors NF-κB and C/EBP in the transcriptional regulation of genes , 1997 .

[36]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[37]  T. Sayers,et al.  Reduced release of TNF and PCA from macrophages of tolerant mice. , 1988, Circulatory shock.

[38]  G. Natoli,et al.  Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Peter J. Murray,et al.  Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.

[40]  T. Kajiji,et al.  Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients , 2009, The Journal of Immunology.

[41]  P. Finan,et al.  IL‐10 expression profiling in human monocytes , 2002, Journal of leukocyte biology.

[42]  D. Golenbock,et al.  Dysregulation of LPS-Induced Toll-Like Receptor 4-MyD88 Complex Formation and IL-1 Receptor-Associated Kinase 1 Activation in Endotoxin-Tolerant Cells1 , 2002, The Journal of Immunology.

[43]  C. McCall,et al.  Induction of RelB Participates in Endotoxin Tolerance1 , 2006, The Journal of Immunology.

[44]  A. Mantovani,et al.  Transcriptional Profiling Reveals Complex Regulation of the Monocyte IL-1β System by IL-131 , 2005, The Journal of Immunology.

[45]  Eric S. Lander,et al.  Genomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse , 2005, Cell.

[46]  Simmie L. Foster,et al.  Gene-specific control of inflammation by TLR-induced chromatin modifications , 2008, Nature.

[47]  L. Wahl,et al.  Endotoxin tolerance dysregulates MyD88‐ and Toll/IL‐1R domain‐containing adapter inducing IFN‐β‐dependent pathways and increases expression of negative regulators of TLR signaling , 2009, Journal of leukocyte biology.

[48]  E. Pearce,et al.  Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern of l-Arginine Metabolism1 , 2001, The Journal of Immunology.

[49]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[50]  A. Ceylan-isik,et al.  Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis. , 2010, Journal of molecular and cellular cardiology.

[51]  M. Ferlito,et al.  Suppression of Cox-2 and TNF-alpha mRNA in endotoxin tolerance: effect of cycloheximide, antinomycin D, and okadaic acid. , 2000, Shock.

[52]  T. Wight,et al.  Proteoglycans in atherosclerosis and restenosis: key roles for versican. , 2004, Circulation research.

[53]  J. Cavaillon The nonspecific nature of endotoxin tolerance. , 1995, Trends in microbiology.

[54]  R. Keep,et al.  CCL2 Regulates Angiogenesis via Activation of Ets-1 Transcription Factor1 , 2006, The Journal of Immunology.

[55]  Fiona S. L. Brinkman,et al.  Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-371 , 2006, The Journal of Immunology.

[56]  D. Laukens,et al.  Human metallothionein expression under normal and pathological conditions: mechanisms of gene regulation based on in silico promoter analysis. , 2009, Critical reviews in eukaryotic gene expression.

[57]  Y. Ohmori,et al.  Requirement for STAT1 in LPS‐induced gene expression in macrophages , 2001, Journal of leukocyte biology.

[58]  D. O’Rourke,et al.  Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. , 2004, Molecular biology of the cell.

[59]  D. Spandidos,et al.  Peripheral monocytes from diabetic patients with coronary artery disease display increased bFGF and VEGF mRNA expression , 2003, Journal of Translational Medicine.

[60]  H. Volk,et al.  Impaired antigen presentation by human monocytes during endotoxin tolerance. , 2000, Blood.

[61]  M. Trojanowska Ets factors and regulation of the extracellular matrix , 2000, Oncogene.

[62]  Liwu Li,et al.  Characterization of Interleukin-1 Receptor-associated Kinase in Normal and Endotoxin-tolerant Cells* , 2000, The Journal of Biological Chemistry.

[63]  F. Larcher,et al.  In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. , 2008, The Journal of investigative dermatology.

[64]  R. Hancock,et al.  Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains , 1983, Journal of bacteriology.

[65]  M. Torii,et al.  Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxin through transcription factor SP-1. , 2001, Journal of medical microbiology.

[66]  C. Bachert,et al.  Comment on “Potent Phagocytic Activity with Impaired Antigen Presentation Identifying Lipopolysaccharide-Tolerant Human Monocytes: Demonstration in Isolated Monocytes from Cystic Fibrosis Patients” , 2009, The Journal of Immunology.

[67]  Navin L Rao,et al.  IRAK1: a critical signaling mediator of innate immunity. , 2008, Cellular signalling.

[68]  E. Clementi,et al.  Inflammatory and alternatively activated human macrophages attract vessel‐associated stem cells, relying on separate HMGB1‐ and MMP‐9‐dependent pathways , 2009, Journal of leukocyte biology.

[69]  A. Chawla,et al.  Alternative macrophage activation and metabolism. , 2011, Annual review of pathology.

[70]  G. Barton,et al.  A calculated response: control of inflammation by the innate immune system. , 2008, The Journal of clinical investigation.

[71]  M. West,et al.  Endotoxin tolerance: A review , 2002, Critical care medicine.

[72]  J. Cavaillon,et al.  Reprogramming of circulatory cells in sepsis and SIRS , 2005, Journal of endotoxin research.